<!DOCTYPE html>
<html>
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><!--[if !mso]><!--><meta http-equiv="X-UA-Compatible" content="IE=edge"><!--<![endif]--><meta name="viewport" content="width=device-width, initial-scale=1.0">
	<title></title>
	<!--[if (gte mso 9)|(IE)]>
    <style type="text/css">
        table {border-collapse: collapse !important;}
    </style>
    <![endif]--><!--[if mso]> 
<style>
    span, td, table, div, p, a {
      font-family: sans-serif, Arial !important;
    }
</style>
<![endif]--><!--[if gte mso 9]><xml>
  <o:OfficeDocumentSettings>
    <o:AllowPNG/>
    <o:PixelsPerInch>96</o:PixelsPerInch>
  </o:OfficeDocumentSettings>
</xml><![endif]-->
	<style type="text/css">@font-face {
  font-family: 'Benton-Regular';
  src: url('https://www.scientificamerican.com/public/resources/fonts/Benton-Regular.woff') format('woff');
  font-weight: normal;
  font-style: normal;
}


@font-face {
  font-family: 'Benton-Bold';
  src: url('https://www.scientificamerican.com/public/resources/fonts/Benton-Bold.woff') format('woff');
  font-weight: bold;
  font-style: normal;
}

@font-face {
  font-family: 'Brunel-Deck-Semibold';
  src: url('https://static.scientificamerican.com/sciam/assets/File/Brunel%20Deck-Semibold.otf') format('truetype');
  font-weight: normal;
  font-style: normal;
}

.appleLinks a {
  text-decoration: none;
  color: #1a1a1a;
}

.appleLinks2 a {
  text-decoration: none;
  color: #545454;
}

.txt-color:hover { text-decoration:underline!important; }

 @media only screen and (max-width:599px) {
    .fullwidth {width:100%!important; max-width:100%!important;}
    .center {text-align:center!important;} 
    .padleftright {padding-left:5%!important;padding-right:5%!important;}
    }
 @media only screen and (max-width:250px) {
      .padleftright {padding-left:3%!important;padding-right:3%!important;}
}
	</style>
	<style type="text/css">.wm-ab-launcher-spinner {
  height: 100%;
  left: 0;
  position: absolute;
  top: 0;
  width: 100%;
}

.wm-ab-launcher-spinner::before {
  animation: wm-ab-spin 1.5s linear infinite;
  border: 2px solid #f3f3f3;
  border-radius: 50%;
  border-top: 2px solid transparent;
  content: '';
  height: 18px;
  left: calc(50% - 9px);
  position: absolute;
  top: calc(50% - 9px);
  width: 18px;
}

@keyframes wm-ab-spin {
  0% {
    transform: rotate(0deg);
  }

  100% {
    transform: rotate(360deg);
  }
}
	</style>
	<style type="text/css">.wm-ab-launcher-spinner {
  height: 100%;
  left: 0;
  position: absolute;
  top: 0;
  width: 100%;
}

.wm-ab-launcher-spinner::before {
  animation: wm-ab-spin 1.5s linear infinite;
  border: 2px solid #f3f3f3;
  border-radius: 50%;
  border-top: 2px solid transparent;
  content: '';
  height: 18px;
  left: calc(50% - 9px);
  position: absolute;
  top: calc(50% - 9px);
  width: 18px;
}

@keyframes wm-ab-spin {
  0% {
    transform: rotate(0deg);
  }

  100% {
    transform: rotate(360deg);
  }
}
	</style>
	<style type="text/css">.wm-ab-launcher-spinner {
  height: 100%;
  left: 0;
  position: absolute;
  top: 0;
  width: 100%;
}

.wm-ab-launcher-spinner::before {
  animation: wm-ab-spin 1.5s linear infinite;
  border: 2px solid #f3f3f3;
  border-radius: 50%;
  border-top: 2px solid transparent;
  content: '';
  height: 18px;
  left: calc(50% - 9px);
  position: absolute;
  top: calc(50% - 9px);
  width: 18px;
}

@keyframes wm-ab-spin {
  0% {
    transform: rotate(0deg);
  }

  100% {
    transform: rotate(360deg);
  }
}
	</style>
	<style type="text/css">.wm-ab-launcher-spinner {
  height: 100%;
  left: 0;
  position: absolute;
  top: 0;
  width: 100%;
}

.wm-ab-launcher-spinner::before {
  animation: wm-ab-spin 1.5s linear infinite;
  border: 2px solid #f3f3f3;
  border-radius: 50%;
  border-top: 2px solid transparent;
  content: '';
  height: 18px;
  left: calc(50% - 9px);
  position: absolute;
  top: calc(50% - 9px);
  width: 18px;
}

@keyframes wm-ab-spin {
  0% {
    transform: rotate(0deg);
  }

  100% {
    transform: rotate(360deg);
  }
}
	</style>
	<style type="text/css">.wm-ab-launcher-spinner {
  height: 100%;
  left: 0;
  position: absolute;
  top: 0;
  width: 100%;
}

.wm-ab-launcher-spinner::before {
  animation: wm-ab-spin 1.5s linear infinite;
  border: 2px solid #f3f3f3;
  border-radius: 50%;
  border-top: 2px solid transparent;
  content: '';
  height: 18px;
  left: calc(50% - 9px);
  position: absolute;
  top: calc(50% - 9px);
  width: 18px;
}

@keyframes wm-ab-spin {
  0% {
    transform: rotate(0deg);
  }

  100% {
    transform: rotate(360deg);
  }
}
	</style>
	<style type="text/css">.wm-ab-launcher-spinner {
  height: 100%;
  left: 0;
  position: absolute;
  top: 0;
  width: 100%;
}

.wm-ab-launcher-spinner::before {
  animation: wm-ab-spin 1.5s linear infinite;
  border: 2px solid #f3f3f3;
  border-radius: 50%;
  border-top: 2px solid transparent;
  content: '';
  height: 18px;
  left: calc(50% - 9px);
  position: absolute;
  top: calc(50% - 9px);
  width: 18px;
}

@keyframes wm-ab-spin {
  0% {
    transform: rotate(0deg);
  }

  100% {
    transform: rotate(360deg);
  }
}
	</style>
</head>
<body style="margin-top:0 !important;margin-bottom:0 !important;margin-right:0 !important;margin-left:0 !important;padding:0;background-color:#ffffff;"><center><font size="1" color="#000000" face="ARIAL">If you are unable to see the message below, <a href="http://links.email.scientificamerican.com/servlet/MailView?ms=NzAyMjEwOTgS1&r=NTIxNDMyMzUxODY5S0&j=MjE0MTM2MTc2OQS2&mt=1&rt=0">click here to view</a>.</font><font face="ARIAL" color="#808080" size="2"><br></font></center>
<center style="width:100%;table-layout:fixed;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%;">
<div style="max-width:600px;margin-top:0;margin-bottom:0;margin-right:auto;margin-left:auto;"><!--[if (gte mso 9)|(IE)]>
            <table width="600" align="center" style="border-spacing:0;font-family:sans-serif;color:#1a1a1a;border:1px solid #cccccc;" >
            <tr>
            <td style="padding:0;" >
            <![endif]-->
<table align="center" cellpadding="0" cellspacing="0" style="border-spacing:0;font-family:sans-serif;color:#1a1a1a;Margin:0 auto;width:100%">
	
		<tr>
			<td style="padding:0;"><a href="http://links.email.scientificamerican.com/els/v2/Eyb3QNWZ_bB3/SnlDWDFoY05hdnl1aklqZHFoTHVVZHRWODBWRzVkSTBaWnoxN2lKL3Y1UXhiNEVpUGVQVzJFNUFtek1yWmpMalcySWNTNDIxcm1MdVB2N2JtaVZNMDFkK21RMTVKbndmclF2dVBjODdOL2M9S0/" name="www_biogen_com" target="_blank"><img alt="Logo" border="0" src="https://www.nature.com/MailArt/biogentpe/biogen.png" style="padding-top:20px;padding-left:20px;" width="176"></a></td>
		</tr>
		<tr>
			<td style="padding:40px 25px 20px 25px;width:100%;text-align:left;">
			<p style="Margin:0;font-family: 'Benton-Regular', sans-serif;font-size:24px;line-height:30px;text-align:left;color:#057FD8;">Researchers have been searching for biomarkers to guide more individualized care for neurological diseases. Neurofilaments could be their answer.</p>
			&nbsp;

			<p br="" style="Margin:0;font-family: 'Benton-Regular', sans-serif;font-size:14px;line-height:20px;text-align:left;color:#1a1a1a;">Spinal muscular atrophy (SMA) is a rare, genetic neuromuscular disease of the central nervous system that affects infants, children and adults. People with SMA will experience a decline in muscle strength throughout the course of their lives and present a spectrum of motor and functional disabilities: Some may never sit, some sit but never walk, and some walk but may lose that ability over time.<br>
			&nbsp;</p>

			<p br="" style="Margin:0;font-family: 'Benton-Regular', sans-serif;font-size:14px;line-height:20px;text-align:left;color:#1a1a1a;">In just the past few years, the treatment landscape for people with SMA has advanced dramatically. Motor function assessments are commonly used to evaluate disease progression and effectiveness of treatment, but SMA is an unpredictable, degenerative disease and its course can vary greatly.<br>
			&nbsp;</p>

			<p br="" style="Margin:0;font-family: 'Benton-Regular', sans-serif;font-size:14px;line-height:20px;text-align:left;color:#1a1a1a;">Identifying a potential biomarker for SMA could help introduce more individualized treatment plans by improving diagnosis and predicting one&rsquo;s response to a therapy sooner. A protein called neurofilament is being studied as a potential biomarker for various neurological diseases, including SMA.<br>
			&nbsp;</p>

			<p br="" style="Margin:0;font-family: 'Benton-Regular', sans-serif;font-size:14px;line-height:20px;text-align:left;color:#1a1a1a;">Read more about neurofilaments in <a href="http://links.email.scientificamerican.com/els/v2/YejaM-7_VDfr/SnlDWDFoY05hdnl1aklqZHFoTHVVZHRWODBWRzVkSTBaWnoxN2lKL3Y1UXhiNEVpUGVQVzJFNUFtek1yWmpMalcySWNTNDIxcm1MdVB2N2JtaVZNMDFkK21RMTVKbndmclF2dVBjODdOL2M9S0/" name="www_scientificamerican_com_custom_m" style="color:#057FD8;" target="_blank"><strong><em>How a Biomarker Could Improve Care for Neurological Diseases in the Future.</em></strong></a><br>
			&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td class="padleftright" style="padding:10px 30px 20px 30px;">
			<table style="border-spacing:0;font-family:sans-serif;color:#1a1a1a;width:100%; max-width:540px;" width="100%">
				
					<tr>
						<td align="center" style="padding:0 0 30px 0;text-align: center;" valign="top"><img alt="Headshot" src="https://www.nature.com/MailArt/biogentpe/marta.png" style="border-style: none; display: block;border: 0 none;outline: none;text-decoration: none;line-height: 100%; mso-line-height-rule: exactly;" width="190"></td>
						<td align="center" style="padding:0 0 30px 0;text-align: center;" width="20">&nbsp;</td>
						<td align="center" style="padding:0 0 30px 0;text-align: center;Margin:0;font-family: 'Benton-Regular', sans-serif;font-size:14px;line-height:20px;text-align:left;color:#1a1a1a;">In <a href="http://links.email.scientificamerican.com/els/v2/drg-CKed6bTK/SnlDWDFoY05hdnl1aklqZHFoTHVVZHRWODBWRzVkSTBaWnoxN2lKL3Y1UXhiNEVpUGVQVzJFNUFtek1yWmpMalcySWNTNDIxcm1MdVB2N2JtaVZNMDFkK21RMTVKbndmclF2dVBjODdOL2M9S0/" name="www_scientificamerican_com_custom_m_2" style="color:#057FD8;" target="_blank"><strong><em>How a Biomarker Could Improve Care for Neurological Diseases in the Future</em></strong></a>, Global Medical Head of Neuromuscular Diseases at Biogen, Marta Valente, PharmD, MBA, explains the benefits of identifying potential biomarkers for SMA and other neurological diseases. At Biogen, Valente works to advance the understanding of SMA and the development of therapeutics that alter the natural course of the disease.</td>
					</tr>
				
			</table>
			</td>
		</tr>
	
</table>
<!--[if (gte mso 9)|(IE)]>
            </td>
            </tr>
            </table>
            
            <table width="600" align="center" style="border-spacing:0;font-family:sans-serif;color:#1a1a1a;" >
            <tr>
            <td style="padding:0;" >
            <![endif]-->

<table align="center" cellpadding="0" cellspacing="0" style="border-spacing:0;font-family:sans-serif;color:#1a1a1a;Margin:0 auto;width:100%;max-width:602px;">
	
		<tr>
			<td style="padding:15px 25px 35px 25px;">
			<table style="border-spacing:0;font-family:sans-serif;color:#838383;width:100%;" width="100%">
				
					<tr>
						<td style="border-collapse:collapse;margin:0;padding:0">
						<div class="email-footer" style="padding:0;text-align:center">
						<table style="width:100%;border-collapse:collapse;margin:0;padding:0">
							
								<tr>
									<td class="email-footer__row" style="padding:1em 0;border-collapse:collapse;margin:0;text-align:center">
									<p style="color:#191919;font-size:13px;margin:0">You received this email because you opted-in to receive email from Scientific American. To ensure delivery please add <a href="mailto:news@email.scientificamerican.com" name="news_email_scientificamerican_" style="text-decoration:none;color:#191919;border-bottom:1px solid #ccc;">news@email.scientificamerican.com</a> to your address book.</p>
									</td>
								</tr>
								<tr>
									<td class="email-footer__row email-footer__row--last" style="padding:1em 0 50px;border-collapse:collapse;margin:0;text-align:center">
									<p class="email-footer__links" style="color:#191919;font-size:13px;margin:0"><a href="http://links.email.scientificamerican.com/els/v2/LyjpQdqA2jM4/SnlDWDFoY05hdnl1aklqZHFoTHVVZHRWODBWRzVkSTBaWnoxN2lKL3Y1UXhiNEVpUGVQVzJFNUFtek1yWmpMalcySWNTNDIxcm1MdVB2N2JtaVZNMDFkK21RMTVKbndmclF2dVBjODdOL2M9S0/" name="www_pages04_net_macmillanlimit" style="text-decoration:none;display:inline-block;padding:0 5px;color:#191919;border-bottom:1px solid #ccc"> </a> <a href="http://links.email.scientificamerican.com/els/v2/vZDYhGzj98FR/SnlDWDFoY05hdnl1aklqZHFoTHVVZHRWODBWRzVkSTBaWnoxN2lKL3Y1UXhiNEVpUGVQVzJFNUFtek1yWmpMalcySWNTNDIxcm1MdVB2N2JtaVZNMDFkK21RMTVKbndmclF2dVBjODdOL2M9S0/" name="www_scientificamerican_com_my_" style="text-decoration:none;display:inline-block;padding:0 5px;color:#191919;border-bottom:1px solid #ccc"> </a> <a href="http://links.email.scientificamerican.com/els/v2/q02ZCq-geRTK/SnlDWDFoY05hdnl1aklqZHFoTHVVZHRWODBWRzVkSTBaWnoxN2lKL3Y1UXhiNEVpUGVQVzJFNUFtek1yWmpMalcySWNTNDIxcm1MdVB2N2JtaVZNMDFkK21RMTVKbndmclF2dVBjODdOL2M9S0/" name="www_scientificamerican_com_pag" style="text-decoration:none;display:inline-block;padding:0 5px;color:#191919;border-bottom:1px solid #ccc">Privacy Policy</a> <a href="http://links.email.scientificamerican.com/els/v2/mr8GCr4WqAfV/SnlDWDFoY05hdnl1aklqZHFoTHVVZHRWODBWRzVkSTBaWnoxN2lKL3Y1UXhiNEVpUGVQVzJFNUFtek1yWmpMalcySWNTNDIxcm1MdVB2N2JtaVZNMDFkK21RMTVKbndmclF2dVBjODdOL2M9S0/" name="www_scientificamerican_co_8" style="text-decoration:none;display:inline-block;padding:0 5px;color:#191919;border-bottom:1px solid #ccc">Contact Us</a></p>
									</td>
								</tr>
							
						</table>
						</div>
						</td>
					</tr>
				
			</table>
			<!--[if (gte mso 9)|(IE)]>
            </td>
            </tr>
            </table>
            <![endif]--></td>
		</tr>
	
</table>
</div>
</center>
<img src="http://open.mkt41.net/open/log/70221098/NTIxNDMyMzUxODY5S0/0/MjE0MTM2MTc2OQS2/1/0" style="display: none"></body>
</html>


